Preeclampsia

rosuvastatin

Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Effect of Rosuvastatin on Sever Preeclampsia Induced Inflammatory Response

The primary outcome will be the effect of rosuvastatin on the resolution of biochemical features associated with severe PE (↑CRP and IL6).

Sara Mansour

assistant lecturer on anasthesia and icu department

Assiut University

. They will be randomly allocated into two equal groups of 40 parturient each: Group 1: 40 preeclamptic parturient receive 20 mg rosuvastatin orally once daily.
Group 2: 40 preeclamptic parturient receive 40 mg rosuvastatin orally once daily

computer generated randomization will be conducted in a Women's Health Hospital, Assuit University. Neither the doctor "investigator" nor the participant "parturient" will be aware of the group allocation or the drug used. The study drugs will be prepared by one of the supervisor anesthesia (not included in the procedure, observation or in data collection)

Stable Coronary Artery Disease Undergoing PCI

Atorvastatin

Rosuvastatin

5 mg twice before PCI (+ 10 mg ezetimibe)

10 mg twice before PCI (+ 5 mg rosuvastatin)

Ezetimibe

placebo

SS. Annunziata Hospital

Fondazione IRCCS Policlinico S. Matteo

A.O. S. Anna e S. Sebastiano - II Università di Napoli

Azienda ASL 6 - P. Ospedaliero Livorno

Ospedale Civile G. Fornaroli

Azienda Ospedaliera - Ospedale San Paolo

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty - The REMEDY Study

The proportion of patients with a post-procedural increase of any measured marker of myocardial injury (CK-MB, troponin I or troponin T) above upper normal limits, measured at any of the post-PCI determinations at up to 48 hours

The combined occurrence of major adverse cardiac events (MACE), including death, myocardial infarction, stroke or the need for unplanned revascularization from the time of the procedure until the end of a 1-month follow-up.

Any post-procedural increase in serum creatinine or decrease in creatinine clearance (Cockcroft-Gault formula)

Changes in HO-1 levels/biologic activity among treated groups(only for sites participating in the specific substudies)

Changes in EPC levels/biologic activity among treated groups (only for sites participating in the specific substudies)

Raffaele De Caterina

Professor, Director - Institute of Cardiology

G. d'Annunzio University

Working Group Aterosclerosi, Trombosi e Biologia Vascolare

Intravenous bone marrow derived mesenchymal stem cells infusion from related donor to patients with relapsed/refractory aplastic anemia.

Aplastic Anemia

Intravenous administration of up to 6x10^5 MSCs per kg,qw,for 4 weeks

bone marrow derived mesenchymal stem cells

Guangzhou General Hospital of Guangzhou Military Command

Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.

PhaseⅠ/ⅡTrial of Bone Marrow Derived Mesenchymal Stem Cell Transplantation From Related Donor to Patients With Relapsed/Refractory Aplastic Anemia.

Jian Liu (President of the hospital)

Guangzhou Municipal Twelfth People's Hospital

Guangdong Prevention and Treatment Center for Occupational Diseases

Type 2 Diabetes Mellitus

Coronary Artery Disease

Ginkgo Biloba Extract 40 mg 1# tid per day for 3 months(90 days)

Ginkgo Biloba Extract (GBE)

Taipei Veterans General Hospital

Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease

oxygenase/nekrózis

Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty

Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.

Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease

A legteljesebb gyógynövény-adatbázis, amelyet a tudomány támogat